US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Evosep Expanding Capabilities with New Headquarters to Support Rising Needs in Pharma and Biotech for Proteomics

HUPO, Dresden, Germany – October 21st, 2024 – Evosep, a global leader in proteomics solutions, is proud to announce its relocation to new headquarters in Odense. This move will significantly enhance the company’s ability to advance the use of proteomics as a vital tool for the pharmaceutical and biotech industries. Building on recent strategic initiatives, the new facility will serve as a hub for continued innovation, reinforcing Evosep’s commitment to improving drug discovery, development, and diagnostics through high-precision proteomics.   The decision to relocate is part of Evosep’

Evosep Unveils Groundbreaking Innovations in Scalable Proteomics Workflows at ASMS 2024

FOR IMMEDIATE RELEASE Mass Spectrometry  Media Contact Information:Christian Ravnsborg+ 45 26 33 20 21cr@evosep.com    Anaheim, CA – ASMS 2024 - June 3rd, 2024 – Evosep, a leader in the field of proteomics, is proud to announce several significant advancements in scalable proteomics workflows at the ASMS 2024 conference in Anaheim. These innovations underline Evosep's commitment to enhancing the efficiency and accessibility of proteomics as a toolbox, specifically targeting the acceleration of the drug discovery process and bridging translational research to proteomics-

Revolutionary Evotip Workflow Enables Unprecedented Proteomic Analysis

FOR IMMEDIATE RELEASE   Proteomics and diagnostics    Media Contact Information:Christian Ravnsborg  +45 26 33 20 21  cr@evosep.com   Making clinical proteomics 100x more robust and 10x faster    [Odense, March 20th, 2024] – Evosep, a leading provider of sample preparation and separation solutions for mass spectrometry-based proteomics, is thrilled to announce the publication of a groundbreaking study in Nature Communications highlighting the capabilities of its innovative Evotip technology.

New developments at Evosep to make clinical proteomics 100x more robust and 10x faster

FOR IMMEDIATE RELEASEMass Spectrometry Media Contact Information:Christian Ravnsborg+ 45 26 33 20 21cr@evosep.com Thermo Fisher and Evosep develop and promote robust high-throughput workflows for clinical proteomics   San Francisco, CA - J.P. Morgan Healthcare Conference – (January 8th, 2024) Evosep, a leading provider of sample preparation solutions for mass spectrometry-based proteomics, today announced a co-marketing agreement with Thermo Fisher Scientific, a world leader in serving science. This collaboration marks a significant milestone in advancing clinical

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe